| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $48.4M | +114.1% |
| Cost of Revenue | $28.7M | +120.1% |
| R&D Expense | $58.1M | +164.0% |
| SG&A Expense | $36.4M | +435.4% |
| Operating Income | -$74.8M | -288.7% |
| Interest Expense | $1.2M | -43.5% |
| Pre-tax Income | -$118.9M | -20.9% |
| Income Tax | -$327K | -1227.6% |
| Net Income | -$88.0M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $219.1M | +1071.7% |
| Accounts Receivable | $13.8M | +134.1% |
| Inventory | $9.1M | +213.1% |
| Current Assets | $248.0M | +727.4% |
| Total Assets | $470.9M | +1240.6% |
| Current Liabilities | $33.7M | -72.4% |
| Long-term Debt | $5.6M | -54.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$55.8M | -163.1% |
| Capital Expenditures | $2.7M | +321.0% |
| Investing Cash Flow | -$84.3M | — |
| Financing Cash Flow | $340.6M | +917.6% |
| Free Cash Flow | -$58.5M | -167.7% |
| +9.7% |
| EPS (Basic) | -$1.26 | +59.6% |
| EPS (Diluted) | -$1.26 | +59.6% |
| Total Liabilities |
| $179.0M |
| +31.0% |
| Stockholders' Equity | $313.0M | +383.8% |